Fuminori Yoshida
Founder at SYMBIO PHARMACEUTICALS LIMITED
Net worth: 1 M $ as of 31/03/2024
Profile
Fuminori Yoshida is the founder of three companies.
He founded Nippon Bio-Rad Laboratories in 1980, Amgen KK in 1993, and SymBio Pharmaceuticals Ltd.
in 2005.
At Nippon Bio-Rad Laboratories, he held the title of President from 1980 to 2010.
At Amgen KK, he held the title of President from 1993 to 2010.
At SymBio Pharmaceuticals Ltd., he currently holds the title of President, CEO & Representative Director.
Mr. Yoshida's former jobs include being the President & Chief Executive Officer of Syntex Japan Co., Ltd., and a Principal at both Mitsubishi Corp.
and AHS Japan, Inc. Mr. Yoshida received his undergraduate degree from Gakushuin University in 1971, and his graduate degrees from Massachusetts Institute of Technology in 1973 and Harvard University in 1975.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/06/2023 | 1,179,700 ( 2.63% ) | 1 M $ | 31/03/2024 |
Fuminori Yoshida active positions
| Companies | Position | Start |
|---|---|---|
| SYMBIO PHARMACEUTICALS LIMITED | Founder | 25/03/2005 |
Former positions of Fuminori Yoshida
| Companies | Position | End |
|---|---|---|
| Syntex Japan Co., Ltd. | President | - |
| AHS Japan, Inc. | Corporate Officer/Principal | - |
Amgen KK
 Amgen KK Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Amgen KK is a wholly owned Japanese affiliate of Amgen Inc., one of the largest independent biotechnology companies in the world. The private company is based in Tokyo, Japan. Amgen KK focuses on disease areas with significant unmet medical needs, including cardiometabolic, oncological, bone, inflammation/immune and neurological diseases. Currently, approximately 600 employees engage in activities from clinical development to sales with the mission of "to serve patients – doing everything we can now, for the patients." The Japanese company was founded by Fuminori Yoshida. Amgen KK was acquired by Takeda Pharmaceutical Co., Ltd. from Amgen, Inc. on March 31, 2008 for $16.58 million. | Founder | - |
| MITSUBISHI CORPORATION | Corporate Officer/Principal | - |
| Nippon Bio-Rad Laboratories | Founder | - |
Training of Fuminori Yoshida
| Harvard University | Graduate Degree |
| Massachusetts Institute of Technology | Graduate Degree |
| Gakushuin University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| MITSUBISHI CORPORATION | Distribution Services |
| SYMBIO PHARMACEUTICALS LIMITED | Health Technology |
| Private companies | 4 |
|---|---|
Amgen KK
Amgen KK Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Amgen KK is a wholly owned Japanese affiliate of Amgen Inc., one of the largest independent biotechnology companies in the world. The private company is based in Tokyo, Japan. Amgen KK focuses on disease areas with significant unmet medical needs, including cardiometabolic, oncological, bone, inflammation/immune and neurological diseases. Currently, approximately 600 employees engage in activities from clinical development to sales with the mission of "to serve patients – doing everything we can now, for the patients." The Japanese company was founded by Fuminori Yoshida. Amgen KK was acquired by Takeda Pharmaceutical Co., Ltd. from Amgen, Inc. on March 31, 2008 for $16.58 million. | Health Technology |
| Nippon Bio-Rad Laboratories | |
| AHS Japan, Inc. | |
| Syntex Japan Co., Ltd. |
- Stock Market
- Insiders
- Fuminori Yoshida
